Tandem Diabetes Care
TNDM
317 hedge funds and large institutions have $2.96B invested in Tandem Diabetes Care in 2024 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 124 increasing their positions, 91 reducing their positions, and 35 closing their positions.
784% more call options, than puts
Call options by funds: $135M | Put options by funds: $15.3M
83% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 35
36% more repeat investments, than reductions
Existing positions increased: 124 | Existing positions reduced: 91
13% more capital invested
Capital invested by funds: $2.63B → $2.96B (+$339M)
9% more funds holding
Funds holding: 291 → 317 (+26)
0.97% more ownership
Funds ownership: 112.95% → 113.92% (+0.97%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$78.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$51.8M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$28.7M |
| 4 |
FAM
Fred Alger Management
New York
|
+$28.2M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$108M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$31.3M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$30.3M |
| 4 |
Jennison Associates
New York
|
-$24.5M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$20.4M |
TNDM Hedge Fund Activity: Q2 2024 in Review
317 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q2 2024, worth a combined $2.96B — up 13% from $2.63B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new TNDM positions and 35 closed out — a net gain of 29 holders — while 124 added to existing stakes and 91 trimmed.
The largest buyer was BlackRock, adding an estimated $78.9M. The largest seller was Marshall Wace, cutting an estimated $108M.
- 317 institutional investors held Tandem Diabetes Care (TNDM) as of Q2 2024, up from 291 in Q1 2024.
- Funds reported $2.96B of Tandem Diabetes Care stock for Q2 2024, up 13% quarter-over-quarter.
- 64 funds opened new Tandem Diabetes Care positions in Q2 2024 and 35 closed out, a net change of +29 holders.
- The largest Tandem Diabetes Care buyer in Q2 2024 was BlackRock, an estimated $78.9M added.
- The largest Tandem Diabetes Care seller in Q2 2024 was Marshall Wace, an estimated $108M sold.
Based on aggregated 13F filings for Q2 2024.